Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Change in Intangibles (2022 - 2025)

Historic Change in Intangibles for Sunshine Biopharma (SBFMW) over the last 4 years, with Q3 2025 value amounting to $26103.0.

  • Sunshine Biopharma's Change in Intangibles fell 7178.63% to $26103.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $615987.0, marking a year-over-year decrease of 3919.97%. This contributed to the annual value of $322258.0 for FY2024, which is 5434.46% down from last year.
  • Per Sunshine Biopharma's latest filing, its Change in Intangibles stood at $26103.0 for Q3 2025, which was down 7178.63% from $390187.0 recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Change in Intangibles peaked at $686044.0 during Q4 2023, and registered a low of -$402296.0 during Q2 2024.
  • Moreover, its 4-year median value for Change in Intangibles was $101767.0 (2022), whereas its average is $146661.5.
  • The largest annual percentage gain for Sunshine Biopharma's Change in Intangibles in the last 5 years was 418527.1% (2024), contrasted with its biggest fall of 15026.19% (2024).
  • Sunshine Biopharma's Change in Intangibles (Quarter) stood at $111015.0 in 2022, then skyrocketed by 517.97% to $686044.0 in 2023, then crashed by 100.7% to -$4830.0 in 2024, then soared by 640.43% to $26103.0 in 2025.
  • Its last three reported values are $26103.0 in Q3 2025, $390187.0 for Q2 2025, and $204527.0 during Q1 2025.